Want to join the conversation?
For 2Q16, $FRAN expects net sales to be $106-110MM, assuming a mid-single digit decrease in comparable sales. Diluted EPS is expected to be $0.16-0.19, which includes a $0.04 per share impact due to the reversal of previously accrued stock-based compensation expense related to the forfeiture of unvested awards granted to the previous CEO.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?